Welcome to the Genome Stability Group pages

Our research focuses on understanding how cells maintain integrity of their genomes in the face of internal and external damage, originating e.g. during DNA replication or upon exposure to chemotherapeutic agents. We use both basic science and translational approaches, the latter concentrating on high-grade serous ovarian cancer patient samples. Our aim is to provide biological insights that will be useful in clinical decision-making, either immediately or in the longer term.
Read more
@LabKauppi

#oncosyshalloween #killercat https://t.co/LmlyYADIjQ

Ever considered a #job that makes a difference? Want to be part of a multidisciplinary team trying to resolve mys… twitter.com/i/web/status/1…

Viimeinen #SuomenSyöpäpotilaat50v tutkimushankewebinaari starttaa 21.10. klo 16. Webinaarin aiheena on… twitter.com/i/web/status/1…

Check our new paper: 18F-EF5 PET/MRI detects heterogenous Hypoxic areas in locally advanced Cervical Cancer. Congra… twitter.com/i/web/status/1…

@TERVA_OvCa

Viikon jutussa akatemiatutkija ja Terva Chemoresponse konsortiumin johtaja Liisa Kauppi pohtii mitkä ominaisuudet y… twitter.com/i/web/status/1…

Sign up for the virtual minisymposium on 18.11. organised by Research Program in Systems Oncology & Department of O… twitter.com/i/web/status/1…

Tärkeä edistysaskel syöpäpotilaiden hoidossa! @HUS_uutisoi @HBiopankki @FicanSouth @iCAN_Finlandtwitter.com/i/web/status/1…

”Me välitämme.” Roosa nauha rinnassa on osoitus tuestamme syöpään sairastuneille ja siitä, että olemme kaikki muka… twitter.com/i/web/status/1…

Recent publications

RSS Feed

No results.